Progress in Reporting Conflict of Interest Among IRB Members

This article originally appeared here.
Share this content:
Progress in Reporting Conflict of Interest Among IRB Members
Progress in Reporting Conflict of Interest Among IRB Members

TUESDAY, July 14, 2015 (HealthDay News) -- Among institutional review board (IRB) members, there has been positive progress in the reporting and management of conflicts of interest, according to a study published online July 13 in JAMA Internal Medicine.

Eric G. Campbell, Ph.D., from Massachusetts General Hospital in Boston, and colleagues examined the nature, extent, and perceived consequences of industry relationships among IRB members in academic health centers. IRB members from the 115 most research-intensive medical schools and teaching hospitals were surveyed; questions were identical to those used in 2005.

The researchers found that the percentage of IRB members with an industry relationship did not change significantly from 2005 through 2014 (37.2 versus 32.1 percent; P = 0.09). There was a decrease in the percentage of members who felt another member did not properly disclose a financial relationship, from 10.8 percent in 2005 to 6.7 percent in 2014 (P = 0.04); the percentage who felt pressure from their institution or department to approve a protocol also decreased (18.6 to 10.0 percent; P < 0.001). There was no change in the percentage of members with a conflict of interest who voted on protocols with which they have a conflict; there was a significant increase in the percentage who said they always disclosed relationships (from 54.9 to 80.0 percent).

"Additional attention should be focused on deterring IRB members from inappropriately voting on or presenting protocols in a biased manner," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Dupilumab Reduces Rate of Severe Asthma Exacerbations

Dupilumab Reduces Rate of Severe Asthma Exacerbations

And, add-on dupilumab reduces glucocorticoid dose in patients with glucocorticoid-treated asthma

Better Social Support Network Protects Black Men Against HIV

Better Social Support Network Protects Black Men Against ...

Social networks of black men who have sex with men influence HIV risk behavior

Recommendations Developed for Managing Postpartum Pain

Recommendations Developed for Managing Postpartum Pain

Impact of medications on mother-infant dyad should be considered, as many women breastfeed

is free, fast, and customized just for you!

Already a member?

Sign In Now »